Which adverse effect is specifically associated with lomitapide and carries a boxed warning?

Enhance your knowledge of antihyperlipidemics and lipid management. Study with multiple choice questions and detailed explanations. Ace your test!

Multiple Choice

Which adverse effect is specifically associated with lomitapide and carries a boxed warning?

The main concept here is safety risk management for lomitapide. This drug inhibits microsomal triglyceride transfer protein, which reduces the export of apoB-containing lipoproteins from the liver. That mechanism can cause fat to accumulate in the liver and trigger liver enzyme elevations, potentially leading to serious hepatotoxicity or hepatic failure. Because of this significant risk, lomitapide carries a boxed warning and requires careful liver function monitoring before and during therapy. That’s why hepatotoxicity is the best answer. Chest pain, influenza, and GI symptoms can occur with many medications or as nonspecific effects, but they do not carry the specific boxed warning for lomitapide.

The main concept here is safety risk management for lomitapide. This drug inhibits microsomal triglyceride transfer protein, which reduces the export of apoB-containing lipoproteins from the liver. That mechanism can cause fat to accumulate in the liver and trigger liver enzyme elevations, potentially leading to serious hepatotoxicity or hepatic failure. Because of this significant risk, lomitapide carries a boxed warning and requires careful liver function monitoring before and during therapy.

That’s why hepatotoxicity is the best answer. Chest pain, influenza, and GI symptoms can occur with many medications or as nonspecific effects, but they do not carry the specific boxed warning for lomitapide.

More practice questions